| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Center for Neurologic Diseases, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115;
Department of Surgery, Diabetes Institute for Immunology and Transplantation, University of Minnesota, Minneapolis, MN 55455; and
Diabetes Research Institute, Cell Transplant Center, University of Miami, Miami, FL 33136
Altered frequency and function of peripheral invariant NKT (iNKT) cells have been implicated in the regulation of murine and human type 1a diabetes. To examine regulatory cells from the site of drainage of autoinflammatory tissue and autoantigenic T cell priming in diabetes, we directly cloned iNKT cells from human pancreatic draining lymph nodes (PLN). From 451 T cell clones from control and diabetic PLN, we derived 55 iNKT cells by two methods and analyzed function by cytokine secretion. iNKT cell clones isolated from control PLN secreted IL-4 and IFN-
upon TCR stimulation. For type 1a diabetic subjects, PLN iNKT cell clones from three samples secreted IFN- and no IL-4. In a rare recent onset diabetic sample with islet-infiltrating CD4+ T cells, the phenotype of PLN iNKT cell clones was mixed. From normal and diabetic PLN, one-third of CD1d tetramer+-sorted T cell clones were reactive with CD1d transfectants or proliferated/secreted cytokine in response to 
-galactosylceramide-pulsed PBMCs; tetramer-staining T cell clones from diabetic PLN did not secrete IL-4. This is the first report directly examining iNKT cells from lymph nodes draining the site of autoimmunological attack in humans; iNKT cells were altered in cytokine secretion as previously reported for circulating iNKT cells in human type 1a diabetes.
This article has been cited by other articles:
|
|
 |
|
  P. CHOPRA, P. DIIORIO, S. C. PINO, S. B. WILSON, N. E. PHILLIPS, J. P. MORDES, A. A. ROSSINI, D. L. GREINER, L. D. SHULTZ, and R. BORTELL Failure of {alpha}-Galactosylceramide to Prevent Diabetes in Virus-inducible Models of Type 1 Diabetes in the Rat In Vivo, March 1, 2009; 23(2): 195 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Peterfalvi, E. Gomori, T. Magyarlaki, J. Pal, M. Banati, A. Javorhazy, J. Szekeres-Bartho, L. Szereday, and Z. Illes Invariant V{alpha}7.2-J{alpha}33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells Int. Immunol., December 1, 2008; 20(12): 1517 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Waziri, B. Killory, A. T. Ogden III, P. Canoll, R. C. E. Anderson, S. C. Kent, D. E. Anderson, and J. N. Bruce Preferential In Situ CD4+CD56+ T Cell Activation and Expansion within Human Glioblastoma J. Immunol., June 1, 2008; 180(11): 7673 - 7680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu and L. V. Kaer Role of NKT Cells in the Digestive System. II. NKT cells and diabetes Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G919 - G922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. C. Kaizer, C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White Gene Expression in Peripheral Blood Mononuclear Cells from Children with Diabetes J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3705 - 3711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. B. Au-Yeung and D. J. Fowell A Key Role for Itk in Both IFN{gamma} and IL-4 Production by NKT Cells J. Immunol., July 1, 2007; 179(1): 111 - 119. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kis, P. Engelmann, K. Farkas, G. Richman, S. Eck, J. Lolley, H. Jalahej, M. Borowiec, S. C. Kent, A. Treszl, et al. Reduced CD4+ subset and Th1 bias of the human iNKT cells in Type 1 diabetes mellitus J. Leukoc. Biol., March 1, 2007; 81(3): 654 - 662. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
